Novavax Stock Price History
NVAX Stock | USD 4.85 0.14 2.97% |
Below is the normalized historical share price chart for Novavax extending back to December 05, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Novavax stands at 4.85, as last reported on the 28th of March, with the highest price reaching 4.85 and the lowest price hitting 4.68 during the day.
If you're considering investing in Novavax Stock, it is important to understand the factors that can impact its price. Novavax appears to be moderately volatile, given 3 months investment horizon. Novavax has Sharpe Ratio of 0.0342, which conveys that the firm had a 0.0342% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Novavax, which you can use to evaluate the volatility of the firm. Please exercise Novavax's Downside Deviation of 5.81, mean deviation of 3.94, and Risk Adjusted Performance of 0.02 to check out if our risk estimates are consistent with your expectations.
At this time, Novavax's Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 1.9 B in 2024, despite the fact that Total Stockholder Equity is likely to grow to (681.1 M). . Price Earnings To Growth Ratio is likely to rise to 0.03 in 2024, whereas Price Earnings Ratio is likely to drop (0.93) in 2024. Novavax Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of December 1995 | 200 Day MA 6.3725 | 50 Day MA 4.5852 | Beta 1.581 |
Novavax |
Sharpe Ratio = 0.0342
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | NVAX | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
6.19 actual daily | 54 54% of assets are less volatile |
Expected Return
0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Novavax is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novavax by adding it to a well-diversified portfolio.
Price Book 49.522 | Enterprise Value Ebitda (0.66) | Price Sales 0.6701 | Shares Float 125.2 M | Wall Street Target Price 15.4 |
Novavax Stock Price History Chart
There are several ways to analyze Novavax Stock price data. The simplest method is using a basic Novavax candlestick price chart, which shows Novavax price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | February 27, 2024 | 6.02 |
Lowest Price | February 5, 2024 | 3.76 |
Novavax March 28, 2024 Stock Price Synopsis
Various analyses of Novavax's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Novavax Stock. It can be used to describe the percentage change in the price of Novavax from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Novavax Stock.Novavax Price Action Indicator | 0.15 | |
Novavax Price Rate Of Daily Change | 1.03 | |
Novavax Price Daily Balance Of Power | 0.82 | |
Novavax Accumulation Distribution | 134,310 |
Novavax March 28, 2024 Stock Price Analysis
Novavax Stock Price History Data
The price series of Novavax for the period between Fri, Dec 29, 2023 and Thu, Mar 28, 2024 has a statistical range of 2.26 with a coefficient of variation of 12.08. The daily prices for the period are spread out with arithmetic mean of 4.67. The median price for the last 90 days is 4.81. The company underwent 1:20 stock split on 10th of May 2019. Novavax issued dividends to stockholders on 2019-05-10.Open | High | Low | Close | Volume | ||
03/27/2024 | 4.73 | 4.85 | 4.68 | 4.85 | 3,831,789 | |
03/26/2024 | 4.89 | 4.92 | 4.70 | 4.71 | 5,206,055 | |
03/25/2024 | 4.68 | 4.91 | 4.66 | 4.81 | 3,578,859 | |
03/22/2024 | 4.69 | 4.77 | 4.63 | 4.70 | 2,792,397 | |
03/21/2024 | 4.86 | 5.07 | 4.71 | 4.72 | 3,959,279 | |
03/20/2024 | 4.95 | 4.95 | 4.64 | 4.83 | 7,322,993 | |
03/19/2024 | 5.07 | 5.16 | 4.92 | 4.94 | 4,012,988 | |
03/18/2024 | 5.24 | 5.37 | 5.10 | 5.14 | 3,148,780 | |
03/15/2024 | 4.97 | 5.40 | 4.91 | 5.29 | 8,809,650 | |
03/14/2024 | 5.20 | 5.27 | 4.92 | 4.98 | 5,167,797 | |
03/13/2024 | 5.05 | 5.29 | 4.99 | 5.25 | 5,140,273 | |
03/12/2024 | 5.16 | 5.22 | 4.98 | 5.06 | 4,056,799 | |
03/11/2024 | 5.45 | 5.62 | 5.12 | 5.13 | 5,822,509 | |
03/08/2024 | 5.68 | 5.98 | 5.43 | 5.45 | 8,244,950 | |
03/07/2024 | 5.67 | 5.83 | 5.56 | 5.61 | 5,942,249 | |
03/06/2024 | 5.65 | 5.81 | 5.41 | 5.61 | 7,676,930 | |
03/05/2024 | 5.37 | 6.00 | 5.34 | 5.57 | 13,740,044 | |
03/04/2024 | 5.44 | 5.58 | 5.10 | 5.49 | 8,903,998 | |
03/01/2024 | 5.09 | 5.50 | 4.76 | 5.39 | 14,761,535 | |
02/29/2024 | 4.40 | 5.11 | 4.38 | 4.94 | 18,975,332 | |
02/28/2024 | 4.64 | 4.70 | 4.23 | 4.41 | 32,154,306 | |
02/27/2024 | 5.61 | 6.05 | 5.53 | 6.02 | 16,233,821 | |
02/26/2024 | 5.41 | 5.73 | 5.28 | 5.50 | 15,143,796 | |
02/23/2024 | 5.06 | 5.46 | 4.91 | 5.29 | 18,619,255 | |
02/22/2024 | 4.46 | 5.46 | 4.38 | 4.88 | 41,440,575 | |
02/21/2024 | 4.13 | 4.22 | 3.92 | 3.98 | 4,843,800 | |
02/20/2024 | 4.16 | 4.23 | 4.08 | 4.13 | 3,390,289 | |
02/16/2024 | 4.22 | 4.31 | 4.11 | 4.16 | 4,127,178 | |
02/15/2024 | 4.11 | 4.35 | 4.07 | 4.30 | 6,615,981 | |
02/14/2024 | 3.97 | 4.15 | 3.87 | 4.10 | 7,051,548 | |
02/13/2024 | 4.03 | 4.04 | 3.81 | 3.90 | 8,255,761 | |
02/12/2024 | 4.09 | 4.34 | 4.00 | 4.15 | 8,239,923 | |
02/09/2024 | 3.83 | 4.14 | 3.74 | 4.03 | 8,211,480 | |
02/08/2024 | 3.68 | 3.80 | 3.60 | 3.79 | 4,680,263 | |
02/07/2024 | 3.93 | 3.93 | 3.75 | 3.78 | 5,171,615 | |
02/06/2024 | 3.77 | 3.95 | 3.70 | 3.93 | 4,607,551 | |
02/05/2024 | 3.83 | 3.86 | 3.53 | 3.76 | 8,976,676 | |
02/02/2024 | 4.01 | 4.02 | 3.82 | 3.93 | 8,278,229 | |
02/01/2024 | 4.05 | 4.09 | 3.99 | 4.02 | 5,143,431 | |
01/31/2024 | 4.01 | 4.24 | 3.95 | 4.00 | 9,108,926 | |
01/30/2024 | 4.18 | 4.22 | 4.02 | 4.03 | 5,640,646 | |
01/29/2024 | 4.07 | 4.20 | 4.01 | 4.19 | 5,706,889 | |
01/26/2024 | 4.17 | 4.23 | 3.98 | 4.06 | 5,161,123 | |
01/25/2024 | 4.07 | 4.18 | 4.04 | 4.10 | 5,299,946 | |
01/24/2024 | 4.32 | 4.35 | 4.02 | 4.05 | 4,946,301 | |
01/23/2024 | 4.32 | 4.36 | 4.12 | 4.26 | 4,804,698 | |
01/22/2024 | 4.06 | 4.29 | 4.02 | 4.18 | 6,117,213 | |
01/19/2024 | 4.11 | 4.12 | 3.99 | 4.05 | 5,736,400 | |
01/18/2024 | 4.11 | 4.15 | 4.01 | 4.11 | 6,245,461 | |
01/17/2024 | 4.22 | 4.25 | 4.15 | 4.21 | 6,091,594 | |
01/16/2024 | 4.43 | 4.48 | 4.28 | 4.34 | 6,955,506 | |
01/12/2024 | 4.56 | 4.73 | 4.54 | 4.58 | 6,254,909 | |
01/11/2024 | 4.80 | 4.81 | 4.55 | 4.56 | 7,829,181 | |
01/10/2024 | 4.87 | 4.92 | 4.70 | 4.84 | 5,078,247 | |
01/09/2024 | 5.10 | 5.10 | 4.63 | 4.81 | 15,422,976 | |
01/08/2024 | 4.96 | 5.19 | 4.88 | 5.15 | 8,966,517 | |
01/05/2024 | 5.02 | 5.11 | 4.86 | 5.00 | 7,695,327 | |
01/04/2024 | 4.91 | 5.20 | 4.82 | 5.16 | 9,632,340 | |
01/03/2024 | 5.00 | 5.00 | 4.78 | 4.89 | 10,315,206 | |
01/02/2024 | 4.82 | 5.34 | 4.77 | 5.03 | 13,487,431 | |
12/29/2023 | 4.90 | 5.02 | 4.80 | 4.80 | 7,088,964 |
About Novavax Stock history
Novavax investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Novavax is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Novavax will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Novavax stock prices may prove useful in developing a viable investing in Novavax
Last Reported | Projected for 2024 | ||
Common Stock Shares Outstanding | 100.8 M | 105.8 M | |
Net Loss | -592.1 M | -562.5 M |
Novavax Stock Technical Analysis
Novavax technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
All Next | Launch Module |
Novavax Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Novavax's price direction in advance. Along with the technical and fundamental analysis of Novavax Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Novavax to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.02 | |||
Jensen Alpha | 0.2177 | |||
Total Risk Alpha | (1.22) | |||
Sortino Ratio | (0) | |||
Treynor Ratio | (0.12) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.Note that the Novavax information on this page should be used as a complementary analysis to other Novavax's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Novavax Stock analysis
When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Novavax's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novavax. If investors know Novavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novavax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.41) | Revenue Per Share 9.762 | Quarterly Revenue Growth (0.18) | Return On Assets (0.17) | Return On Equity (8.98) |
The market value of Novavax is measured differently than its book value, which is the value of Novavax that is recorded on the company's balance sheet. Investors also form their own opinion of Novavax's value that differs from its market value or its book value, called intrinsic value, which is Novavax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novavax's market value can be influenced by many factors that don't directly affect Novavax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novavax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novavax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novavax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.